DataDirect Networks Case Studies The Institute of Cancer Research, London: Driving the Future of Dynamic Adaptive Therapies

Edit This Case Study Record

	The Institute of Cancer Research, London: Driving the Future of Dynamic Adaptive Therapies DataDirect Networks

The Institute of Cancer Research, London: Driving the Future of Dynamic Adaptive Therapies

DataDirect Networks

Technology Category	Infrastructure as a Service (IaaS) - Cloud Storage Services Infrastructure as a Service (IaaS) - Hybrid Cloud
Applicable Industries	Life Sciences
Applicable Functions	Product Research & Development
Use Cases	Edge Computing & Edge Intelligence Predictive Maintenance
Services	Cloud Planning, Design & Implementation Services Data Science Services
Challenge	The Institute of Cancer Research (ICR) in London, a world leader in identifying cancer genes, discovering cancer drugs and developing precision radiotherapy, needed a single, central storage infrastructure that would enable users to collect and analyze all types of active research data. The research data service (RDS) had to be broad enough to support eight research divisions and all types of biology, chemistry and physics-related data. It needed to be able to pull in massive amounts of data from different scientific instruments and next-generation sequencers while connecting to various research services from laptops and desktops of every flavor, to high performance supercomputers with CPUs and GPUs. Read More
About Customer	The Institute of Cancer Research, London, is one of the world’s most influential cancer research organizations, with an outstanding record of achievement dating back more than 100 years. The Institute of Cancer Research (ICR) is led by Chief Executive, Professor Paul Workman — an expert in cancer drug discovery. It is a world leader in identifying cancer genes, discovering cancer drugs and developing precision radiotherapy. Together with hospital partner, The Royal Marsden NHS Foundation Trust, the pair is rated in the top four centers for cancer research and treatment worldwide. With 140 research teams focused on driving the future of dynamic adaptive therapies, ICR must be diligent in adapting support services. Read More
Solution	ICR set out to deploy a scalable solution that would host a wide range of scientific and clinical data. They chose DDN’s GS7K® as a stretched cluster with synchronous mirroring between sites. Additionally, 4PB of WOS object storage was installed to provide a tier that is protected using Global ObjectAssure® (GOA) advanced erasure coding. The sites are connected with private 10Gbps network links, with an option to increase bandwidth as needed. The infrastructure is extremely resilient with replication and erasure coding across three geographically separate locations, snapshots. The new RDS service is designed to be scalable, cost-effective, and highly resilient – an infrastructure scalable both in front-end performance and back-end capacity that can easily increase to meet changing demand. Read More Log in to view content
Contents

Technology Category

Infrastructure as a Service (IaaS) - Cloud Storage Services

Infrastructure as a Service (IaaS) - Hybrid Cloud

Applicable Industries

Life Sciences

Applicable Functions

Product Research & Development

Use Cases

Edge Computing & Edge Intelligence

Predictive Maintenance

Services

Cloud Planning, Design & Implementation Services

Data Science Services

Challenge

The Institute of Cancer Research (ICR) in London, a world leader in identifying cancer genes, discovering cancer drugs and developing precision radiotherapy, needed a single, central storage infrastructure that would enable users to collect and analyze all types of active research data. The research data service (RDS) had to be broad enough to support eight research divisions and all types of biology, chemistry and physics-related data. It needed to be able to pull in massive amounts of data from different scientific instruments and next-generation sequencers while connecting to various research services from laptops and desktops of every flavor, to high performance supercomputers with CPUs and GPUs.

About Customer

The Institute of Cancer Research, London, is one of the world’s most influential cancer research organizations, with an outstanding record of achievement dating back more than 100 years. The Institute of Cancer Research (ICR) is led by Chief Executive, Professor Paul Workman — an expert in cancer drug discovery. It is a world leader in identifying cancer genes, discovering cancer drugs and developing precision radiotherapy. Together with hospital partner, The Royal Marsden NHS Foundation Trust, the pair is rated in the top four centers for cancer research and treatment worldwide. With 140 research teams focused on driving the future of dynamic adaptive therapies, ICR must be diligent in adapting support services.

Solution

ICR set out to deploy a scalable solution that would host a wide range of scientific and clinical data. They chose DDN’s GS7K® as a stretched cluster with synchronous mirroring between sites. Additionally, 4PB of WOS object storage was installed to provide a tier that is protected using Global ObjectAssure® (GOA) advanced erasure coding. The sites are connected with private 10Gbps network links, with an option to increase bandwidth as needed. The infrastructure is extremely resilient with replication and erasure coding across three geographically separate locations, snapshots. The new RDS service is designed to be scalable, cost-effective, and highly resilient – an infrastructure scalable both in front-end performance and back-end capacity that can easily increase to meet changing demand.

Impact #1	The solution provides a resilient fast access tier for tough workloads, with a transparently integrated object tier that delivers a simple single namespace and provides multi-site data protection for longer term data storage.
Impact #2	Not only can the ICR give users confidence that research data is easily accessible regardless of storage tier, it’s well placed to keep pace with evolving scientific and clinical requirements.
Impact #3	In the future, researchers will be able to manage their data from inception, through to long term storage.

Impact #1

The solution provides a resilient fast access tier for tough workloads, with a transparently integrated object tier that delivers a simple single namespace and provides multi-site data protection for longer term data storage.

Impact #2

Not only can the ICR give users confidence that research data is easily accessible regardless of storage tier, it’s well placed to keep pace with evolving scientific and clinical requirements.

Impact #3

In the future, researchers will be able to manage their data from inception, through to long term storage.

Benefit #1	2PB of usable storage in DDN’s GS7K®
Benefit #2	4PB of WOS object storage
Benefit #3	Sites are connected with private 10Gbps network links

Benefit #1

2PB of usable storage in DDN’s GS7K®

Benefit #2

4PB of WOS object storage

Benefit #3

Sites are connected with private 10Gbps network links

Download PDF Version

Overview

The Institute of Cancer Research, London: Driving the Future of Dynamic Adaptive Therapies

Operational Impact

Quantitative Benefit